Browse by Journal Title

2010

Cellular pharmacology of the anti-hepatitis B virus agent beta-L-2',3'-didehydro-2',3'-dideoxy-N4-hydroxycytidine: relevance for activation in HepG2 cells.
Matthes, E. and Buenger, H.
Antimicrobial Agents and Chemotherapy 54 (1): 341-345. 16 January 2010

2007

Strong and selective inhibitors of HBV-replication between novel N4-hydroxy-and 5-methyl-beta-L-deoxycytidine analogues.
Matthes, E., Funk, A., Krahn, I., Gaertner, K., von Janta-Lipinski, M., Lin, L., Will, H. and Sirma, H.
Antimicrobial Agents and Chemotherapy 51 (7): 2523-2530. July 2007

1996

Inhibition of duck hepatitis B virus replication by 2',3'-Dideoxy-3'-Fluoroguanosine in vitro and in vivo.
Hafkemeyer, P., Keppler-Hafkemeyer, A., al Haya, M.A., von Janta-Lipinski, M., Matthes, E., Lehmann, C., Offensperger, W.B., Offensperger, S., Gerok, W. and Blum, H.E.
Antimicrobial Agents and Chemotherapy 40 : 792-794. 1 January 1996

1991

Comparative inhibition of hepatitis B virus and DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and other nucleoside analogs.
Matthes, E., Reimer, K., von Janta-Lipinski, M., Meisel, H. and Lehmann, C.
Antimicrobial Agents and Chemotherapy 36 : 1254-1257. 1 January 1991